It can be used to examine individual cells, or even thousands at once, which is a major help for research aimed at, for example, more accurate diagnoses and the development of new therapies.
The instrument park of the Hungarian Center of Excellence in Molecular Medicine (HCEMM) has been expanded with a machine capable of examining even a single cell, aimed at developing more accurate diagnoses and new therapies.
HCEMM wrote that the HUF 40 million Chromium Controller instrument, whose operator recently joined the group, is suitable for outstanding measurement services. It can be used to examine individual cells, or even thousands at once, which is a major help for research aimed at, for example, more accurate diagnoses and the development of new therapies.
As is well known, the Single Cell Omics Instrument Center was established in the Szeged Biological Research Center under the leadership of Zsuzsanna Darula in association with the HCEMM. Omics, the collective name for testing methods that map the molecular functioning of living organisms, is a term often mentioned in the field of life sciences recently. For example, genomics deals with the genome, the gene set of living organisms, lipidomics with the fatty acids found in them, and proteomics with proteins.
According to the announcement, the mission of the Szeged group is to provide wide-ranging, high-tech molecular measurement procedures and expertise to the research work carried out at the HCEMM, the Szeged Biological Research Center, Semmelweis University and the University of Szeged. Quoting the head of the instrument center, the press release said that with the help of the new 10× Chromium Controller, individual cells can be isolated and grouped quickly and in large batches, which allows, for example, to reveal the differences between tumor cells living in tumors and to better understand why certain cells become resistant. against treatments.
“Since these research support devices are extremely expensive, the capacities are grouped into instrument parks and operate as a kind of service center, so the measurement needs of several research groups can be met simultaneously, either here or abroad,” highlighted Zsuzsanna Darula.
The head of the instrument center considers the spread of single-cell diagnostics to be possible even in public examinations in ten years’ time, which would create the possibility of predicting certain diseases and for personalized medicine, the announcement reads.
